PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα
2023 · Oncogene · 30 citations
https://doi.org/10.1038/s41388-023-02905-1
X
Xin Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
72
Citations
5
h-index
1
i10-index
Xin Li is an academic researcher from Nanchang University. The author has contributed to research in topics: Ubiquitin and proteasome pathways & Hippo pathway signaling and YAP/TAZ & Cancer-related Molecular Pathways. The author has an h-index of 5, co-authored 8 publications.
ORCID: 0009-0007-3315-3408Papers by this author
worksUSP12 facilitates gastric cancer progression via stabilizing YAP
2024 · Cell Death Discovery · 9 citations
https://doi.org/10.1038/s41420-024-01943-2
Regulation of Hippo/YAP axis in colon cancer progression by the deubiquitinase JOSD1
2024 · Cell Death Discovery · 9 citations
https://doi.org/10.1038/s41420-024-02136-7
<i>Helicobacter pylori</i> infection induces DNA double-strand breaks through the ACVR1/IRF3/POLD1 signaling axis to drive gastric tumorigenesis
2025 · Gut Microbes · 9 citations
https://doi.org/10.1080/19490976.2025.2463581
Design, synthesis and biological evaluation of novel curcumin-fluorouracil hybrids as potential anti-cancer agents
2024 · Biochemical Pharmacology · 6 citations
https://doi.org/10.1016/j.bcp.2024.116559
Anti-inflammatory effects of para-quinone methide derivatives on ulcerative colitis
2024 · Frontiers in Pharmacology · 2 citations
https://doi.org/10.3389/fphar.2024.1474678
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat